AGARWALEYE - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.5
| Stock Code | AGARWALEYE | Market Cap | 14,108 Cr. | Current Price | 445 ₹ | High / Low | 568 ₹ |
| Stock P/E | 239 | Book Value | 61.8 ₹ | Dividend Yield | 0.00 % | ROCE | 5.94 % |
| ROE | 1.31 % | Face Value | 1.00 ₹ | DMA 50 | 444 ₹ | DMA 200 | 454 ₹ |
| Chg in FII Hold | -0.12 % | Chg in DII Hold | 0.05 % | PAT Qtr | 14.6 Cr. | PAT Prev Qtr | 4.95 Cr. |
| RSI | 53.0 | MACD | 3.07 | Volume | 83,880 | Avg Vol 1Wk | 68,682 |
| Low price | 327 ₹ | High price | 568 ₹ | PEG Ratio | 1.57 | Debt to equity | 0.30 |
| 52w Index | 49.0 % | Qtr Profit Var | 80.3 % | EPS | 1.75 ₹ | Industry PE | 47.1 |
📊 AGARWALEYE is trading near its 50 DMA (444 ₹) and slightly below the 200 DMA (454 ₹), showing neutral momentum. RSI at 53.0 indicates mild strength, while MACD at 3.07 reflects weak bullish divergence. Current volume (83,880) is slightly above average (68,682), suggesting modest participation. Bollinger Bands place price mid-range, pointing to consolidation with limited upside.
🎯 Entry Zone: 438 ₹ – 445 ₹ (support near 50 DMA)
💰 Exit Zone: 455 ₹ – 465 ₹ (resistance near 200 DMA)
🔄 Trend Status: Consolidating with mild bullish bias
Positive
- Quarterly PAT growth (14.6 Cr vs 4.95 Cr) highlights strong earnings improvement.
- Price near 50 DMA support provides short-term stability.
- DII holdings increased (+0.05%), showing domestic institutional support.
- PEG ratio (1.57) indicates fair growth-adjusted valuation.
Limitation
- Extremely high P/E (239) compared to industry PE (47.1) signals severe overvaluation.
- Weak ROE (1.31%) and ROCE (5.94%) highlight poor efficiency.
- Trading below 200 DMA shows medium-term weakness.
- Low liquidity with modest trading volume limits conviction.
Company Negative News
- Decline in FII holdings (-0.12%) signals reduced foreign investor confidence.
- Fundamentals remain weak despite profit improvement.
Company Positive News
- Quarterly profit surge (+80.3%) highlights operational recovery.
- DII inflows reflect domestic institutional confidence.
Industry
- Industry PE at 47.1 is far lower than AGARWALEYE’s 239, highlighting valuation risk.
- Healthcare and diagnostics sector remains resilient but faces margin pressures.
Conclusion
⚖️ AGARWALEYE is consolidating with mild bullish bias, supported by short-term technicals but constrained by weak fundamentals and stretched valuations. Entry near 438–445 ₹ with exits around 455–465 ₹ is favorable for speculative trades. Long-term investors should be cautious due to poor efficiency metrics despite profit recovery.
This is the short-term technical trade view. I can also prepare a swing trade overlay benchmarking AGARWALEYE against other healthcare peers to refine entry/exit strategies for your workflow reports.